TOP TIERMARKET NEWSWIRE
News & sentiment

TSCAN THERAPEUTICS I (TCRX) — News & AI sentiment

TSCAN THERAPEUTICS I (TCRX) news roundup. 4 stories in the past week, 6 over 30 days. Average 30-day sentiment is 47.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 46/100
30d stories
6
avg sentiment 47.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

TCRX news in the last 24 hours, 7 days, 30 days and 90 days

How much TCRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTCRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days446/100TCRX headlines →
Last 30 days647.3/100TCRX headlines →
Last 90 days2245.5/100TCRX headlines →

Latest stories on TCRX

1d ago
2d ago
2d ago
2d ago
Oct 16
Oct 16
Sep 30
Sep 11
Sep 11
Sep 8
Sep 4
Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Why is TScan Therapeutics stock collapsing today?
Investing.com Markets32 · bearishgeneral
Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Aug 18
H.C. Wainwright reiterates Tscan Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 13
Aug 12
Aug 12
Open TCRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →